Integra Lifesciences Holdings (IART) Free Cash Flow Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -14.34% |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 193.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 193.48% |
| Mar 31, 2026 | 87.44% |
| Dec 31, 2025 | -125.53% |
| Sep 30, 2025 | 459.59% |
| Jun 30, 2025 | -204.98% |
| Mar 31, 2025 | -13,906.53% |
| Dec 31, 2024 | -38.21% |
| Sep 30, 2024 | -152.30% |
| Jun 30, 2024 | -16.00% |
| Mar 31, 2024 | -97.66% |
| Dec 31, 2023 | -51.73% |
| Sep 30, 2023 | -76.86% |
| Jun 30, 2023 | -77.69% |
| Mar 31, 2023 | -64.44% |
| Dec 31, 2022 | 69.36% |
| Sep 30, 2022 | -21.64% |
| Jun 30, 2022 | -32.58% |
| Mar 31, 2022 | -43.89% |
| Dec 31, 2021 | -41.74% |
| Sep 30, 2021 | 20.00% |